Author name: mikeatshd

Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test

San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) — Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in anticipation of a Series B financing in 2025. Proceeds will support the continued commercialization of Mindera’s lead product, Mind.Px™. “This capital raise will fuel

Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test Read More »